• Accueil >
  • Publications >
  • Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

1 déc. 2019Journal for ImmunoTherapy of Cancer

DOI : 10.1186/s40425-019-0803-x

Auteurs

Marcela Carausu, Arnaud Beddok, Adriana Langer, Nicolas Girard, François-Clément Bidard, Marie-Ange Massiani, Damien Ricard, Luc Cabel